ABSTRACT
Imaging-guided interventional procedures are widely used in the diagnosis, treatment, and follow-up of breast diseases. Suspicious lesions detected by mammography, ultrasonography, or breast Magnetic Resonance Imaging are indicated for imaging-guided biopsy. Biopsy is required in high-risk women, and in patients newly diagnosed cancer even if the finding is not highly suspicious for malignancy. It is possible to evaluate biopsy options for non-mass lesions, such as masses, according to guiding methods.
References
1D’Orsi CJ, Sickles EA, Mendelson EB et al. ACR BI-RADS Atlas, breast imaging reporting and data system. American Collage of Radiology 2013, Reston.
2Choe J, Chikarmane SA, Giess CS. Nonmass findings at breast US: definition, classifications, and differential diagnosis. Radiographics 2020; 40: 326-35.
3Helbich TH, Matzek W, Fuchsjäger MH. Stereotactic and ultrasound-guided breast biopsy. Eur Radiol 2004; 14: 383-93.
4Schueller G, Schueller-Weidekamm C, Helbich TH. Accuracy of ultrasound-guided, large-core needle breast biopsy. Eur Radiol 2008; 18: 1761-73.
5Youk JH, Kim EK, Kim MJ, Lee JY, Oh KK. Missed breast cancers at US-guided core needle biopsy: how to reduce them. Radiographics 2007; 27: 79-94.
6O’Flynn EA, Wilson AR, Michell MJ. Image-guided breast biopsy: state-of-the-art. Clin Radiol 2010; 65: 259-70.
7Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007; 109: 487-95.
8Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 2011; 260: 119-28.
9Rageth CJ, O’Flynn EAM, Pinker K, Kubik-Huch RA, Mundinger A, Decker T, et al. Second international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2019; 174: 279-96.
10Ambinder EB, Plotkin A, Euhus D, Mullen LA, Oluyemi E, Di Carlo P, et al. Tomosynthesis-guided vacuum-assisted breast biopsy of architectural distortion without a sonographic correlate: a retrospective review. AJR Am J Roentgenol. 2021; 217: 845-54.
11den Dekker BM, van Diest PJ, de Waard SN, Verkooijen HM, Pijnappel RM. Stereotactic 9-gauge vacuum-assisted breast biopsy, how many specimens are needed? Eur J Radiol 2019; 120: 108665.
12Mariscotti G, Durando M, Ruggirello I, Belli P, Caumo F, Nori J, et al. Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: Predictors of malignancy. Eur J Radiol 2020; 130: 109194.
13Weaver O, Cohen EO, Perry RE, Tso HH, Phalak K, Srinivasan A, et al. Does lateral arm technique decrease the rate of clip migration in stereotactic and tomosynthesis-guided biopsies? Insights Imaging 2021; 12: 193.
14Lee IT, Ma KS, Luan YZ, Chen JL. Immediate clip migration after breast biopsy: a meta-analysis for potential risk factors. Br J Radiol 2022; 95: 20220195.
15Bartels AK, Fadare O, Hasteh F, Zare SY. Nonmass enhancement lesions of the breast on core needle biopsy: outcomes, frequency of malignancy, and pathologic findings. Hum Pathol 2021; 111: 92-7.
16Chopier J, Dratwa C, Antoine M, Gonin J, Thomassin Naggara I. Radiopathological correlations: masses, non-masslike enhancements and MRI-guided biopsy. Diagn Interv Imaging 2014; 95: 213-25.
17Taşkın F, Soyder A, Tanyeri A, Öztürk VS, Ünsal A. Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy. Diagn Interv Radiol 2017; 23: 333-8.
18Chadashvili T, Ghosh E, Fein-Zachary V, Mehta TS, Venkataraman S, Dialani V, et al. Nonmass enhancement on breast MRI: review of patterns with radiologic-pathologic correlation and discussion of management. AJR Am J Roentgenol 2015; 204: 219-27.
19Raza S, Vallejo M, Chikarmane SA, Birdwell RL. Pure ductal carcinoma in situ: a range of MRI features. AJR Am J Roentgenol 2008; 191: 689-99.
20Lamb LR, Lehman CD, Oseni TO, Bahl M. Ductal carcinoma in situ (DCIS) at breast MRI: predictors of upgrade to invasive carcinoma. Acad Radiol 2020; 27: 1394-9.
21Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 2011; 260: 119-28.
22Taskin F, Kalayci CB, Tuncbilek N, Soydemir E, Kurt N, Kaya H, et al. The value of MRI contrast enhancement in biopsy decision of suspicious mammographic microcalcifications: a prospective multicenter study. Eur Radiol 2021; 31: 1718-26.
23Fueger BJ, Clauser P, Kapetas P, Pötsch N, Helbich TH, Baltzer PAT. Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis. Breast 2021; 56: 53-60.
24Michaels AY, Ginter PS, Dodelzon K, Naunheim MR, Abbey GN. High-risk lesions detected by MRI-guided core biopsy: upgrade rates at surgical excision and implications for management. AJR Am J Roentgenol 2021; 216: 622-32.
25Cullinane C, Byrne J, Kelly L, O Sullivan M, Antony Corrigan M, Paul Redmond H. The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review & meta-analysis. Eur J Surg Oncol 2022; 48: 1464-74.
26Cha E, Ambinder EB, Oluyemi ET, Mullen LA, Panigrahi B, Rossi J, et al. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy. Breast Cancer Res Treat 2022; 196: 517-25.
27Lucioni M, Rossi C, Lomoro P, Ballati F, Fanizza M, Ferrari A, et al. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? Eur Radiol 2021; 31: 920-7.
